The IVO’s Dermatology Department provides comprehensive care in the field of Oncological Dermatology, through innovative diagnostic and treatment techniques for skin cancer, being pioneers in implementing techniques such as Mohs surgery, sentinel node in melanoma and photodynamic therapy.
It is organized in three units: The Mohs Surgery Unit, which has positioned the IVO as national reference centre for the treatment of cutaneous carcinomas, being the first centre in Spain to introduce this technique in hospitals in 1993. This specialized micrographic Mohs surgery technique achieves high cure rates in complex conditions where conventional surgery has not obtained satisfactory results. It is the most effective technique for non-melanoma skin cancer. It involves the removal of the skin tumours at the same time as an analysis of the entire intraoperative surgical margin is carried out, to ensure the complete removal of the tumour.
The Photodynamic Therapy Unit, a pioneering initiative in Spain that makes it possible to treat cutaneous cancer and precancerous cutaneous lesions without surgery.
The Melanoma and Pigmented Lesions Unit provides treatment and follow-up of patients who suffer from these conditions. This unit was a pioneer in the use of the most advanced techniques for early diagnosis in patients at high risk through the use of digital dermoscopy. It is staffed by specialists that are exclusively dedicated to this type of patients, allowing highly specialized monitoring.
The unit is specialized in the study of histological diagnosis, epidemiology, molecular biology of melanoma, genetic predisposition, and the immune response in melanoma. It has developed a wide variety of research projects upon these subjects, both in-house and in collaboration with both international (National Cancer Institute, German Cancer Research Center, DeCODE Genetics, Queensland Melanoma Project, GenoMEL, BioGenoMEL) and Spanish (Registro Nacional de Melanoma de la Academia Española de Dermatología y Venereología) work groups, all of which are at the forefront of research in melanoma.
It participates in and coordinates the Melanoma Committee, where a multidisciplinary team of professionals (dermatology, medical oncology, surgery, radiation oncology, pathology, molecular biology, diagnostic radiology, nuclear medicine and ENT) weekly defines the best therapeutic strategy, tailored to each patient.
The Dermatology Department’s research activity is constant and their participation in clinical trials of new drugs for the treatment of locally advanced basal cell carcinoma, non-melanoma skin cancer and actinic keratoses offers opportunities for patients to access new drugs and/or combinations of surgical techniques. Moreover, they have an intimate relationship with the Oncology Service in the clinical trial of new drugs in the treatment of melanoma, which they actively participate in.
Its professionals have ample experience in the treatment of dermatofibrosarcoma protuberans through deferred Mohs surgery, making it a global reference centre in the diagnosis and management of this skin tumour with an experience garnered from the treatment of more than 200 cases, one of the largest series in the world.
The Instituto Valenciano de Oncología Foundation has an accredited slot for specialized medical training (MIR) residencies in Medical-Surgical Dermatology and Venereology. See call for tender.
Head of Deparment
Dr. Carlos Guillén Barona
Head of Department
Dr. Carlos Guillén Barona
Heads of Section
Dr. Eduardo Nagore Enguídanos
Dr. Onofre Sanmartín Jiménez
Dra. Beatriz Llombart Cussac
Dra. Celia Requena Caballero
Dr. Carlos Serra Guillén
Eduardo Bernia Petit
Adrián Diago Irache
Fátima María Mayo Martínez
Elisa Rios Viñuela